Primary glioblastoma multiforme tumors and recurrence

Sensitizing tumor cells to radiation by targeting the heat shock response

(2015) Daniela Schilling et al.   CANCER LETTERS

The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulation

(2015) Gabriele Multhoff et al.   CANCER LETTERS

Current challenges in designing GBM trials for immunotherapy

(2015) Shiao-Pei Weathers et al.   JOURNAL OF NEURO-ONCOLOGY

Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway

(2015) Qingling Li et al.   Oncotarget

Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma

(2014) Kristen A Batich et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Towards developing biomarkers for glioblastoma multiforme: a proteomics view

(2014) Savita Jayaram et al.   Expert Review of Proteomics

Reliability of HSP70 (HSPA) expression as a prognostic marker in glioma

(2014) Glenda Maria Beaman et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines

(2014) Yvonne Rubner et al.   Radiation Oncology

Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma

(2014) M. Balducci et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation

(2014) Lotte Spel et al.   OncoImmunology

Clinical evaluation of systemic and local immune responses in cancer: time for integration

(2013) Dmitriy W. Gutkin et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Calreticulin expression in infiltrating ductal breast carcinomas: relationships with disease progression and humoral immune responses

(2013) Maria Kabbage et al.   TUMOR BIOLOGY

Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response

(2013) Giovanna Schiavoni et al.   Frontiers in Immunology

Immunogenic cell death in radiation therapy

(2013) Lorenzo Galluzzi et al.   OncoImmunology

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

(2012) Hilko Ardon et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Induction of Abscopal Anti-Tumor Immunity and Immunogenic Tumor Cell Death by Ionizing Irradiation - Implications for Cancer Therapies

(2012) B. Frey et al.   CURRENT MEDICINAL CHEMISTRY

Dual Role of Heat Shock Proteins (HSPs) in Anti-Tumor Immunity

(2012) G. Multhoff et al.   CURRENT MOLECULAR MEDICINE

Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer

(2012) Guo-Liang Yang et al.   JOURNAL OF SURGICAL ONCOLOGY

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy

(2012) Furong Liu et al.   Journal of Translational Medicine

High-Mobility Group Box 1 Release and Redox Regulation Accompany Regeneration and Remodeling of Skeletal Muscle

(2011) Michela Vezzoli et al.   ANTIOXIDANTS & REDOX SIGNALING

Calreticulin as a potential diagnostic biomarker for lung cancer

(2011) Rongrong Liu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-κB

(2011) Marco Tafani et al.   CARCINOGENESIS

Vaccines for glioblastoma and high-grade glioma

(2011) Christopher J Wheeler et al.   Expert Review of Vaccines

Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma

(2011) Marco Tafani et al.   Journal of Neuroinflammation

Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages

(2011) Petra Schildkopf et al.   RADIOTHERAPY AND ONCOLOGY

Identification of diagnostic serum protein profiles of glioblastoma patients

(2010) Anja Elstner et al.   JOURNAL OF NEURO-ONCOLOGY

A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas

(2010) Stefanie Burghaus et al.   VIRCHOWS ARCHIV

Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer

(2010) Rui-Qing Peng   WORLD JOURNAL OF GASTROENTEROLOGY

Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas

(2010) Guoqiang Bao et al.   World Journal of Surgical Oncology

Dendritic Cell Therapy of High-Grade Gliomas

(2009) Stefaan Van Gool et al.   BRAIN PATHOLOGY

Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity

(2009) M. Candolfi et al.   CLINICAL CANCER RESEARCH

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression

(2009) James F Curtin et al.   PLOS MEDICINE

Identification of Calreticulin as a Prognosis Marker and Angiogenic Regulator in Human Gastric Cancer

(2008) Chiung-Nien Chen et al.   ANNALS OF SURGICAL ONCOLOGY

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE